| 000 | 01046 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517133942.0 | ||
| 264 | 0 | _c20190312 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-017-2922-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHilgendorf, Inken | |
| 245 | 0 | 0 |
_aVaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered? _h[electronic resource] |
| 260 |
_bAnnals of hematology _c04 2017 |
||
| 300 |
_a701-702 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCommunicable Diseases |
| 650 | 0 | 4 | _aGraft vs Host Disease |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aGreinix, Hildegard | |
| 700 | 1 | _aHalter, Jörg | |
| 700 | 1 | _aLawitschka, Anita | |
| 700 | 1 | _aWolff, Daniel | |
| 773 | 0 |
_tAnnals of hematology _gvol. 96 _gno. 4 _gp. 701-702 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-017-2922-0 _zAvailable from publisher's website |
| 999 |
_c26794003 _d26794003 |
||